Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ESAB Corporation filings document the regulatory record for an industrial manufacturer of welding, cutting and joining equipment and consumables. Its Form 8-K disclosures cover operating and financial results, material-event reporting, dividend and capital-structure matters, senior unsecured notes and related subsidiary guarantees.
Proxy and governance filings describe shareholder voting matters, director and officer changes, board committee assignments, executive compensation, director independence and related governance practices. The filing record also reflects public-company reporting following ESAB's 2022 registration as a standalone issuer.
ESAB Corporation reported the voting results from its 2026 Annual Meeting of Stockholders. Shareholders elected nine directors to the board, with each nominee receiving over 55 million votes in favor and broker non-votes recorded on the proposals.
Stockholders also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, with 58,527,946 votes for and 107,989 against. In addition, shareholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 53,998,529 votes for and 3,548,562 against.
ESAB Corp director Stephanie M. Phillipps reported routine equity compensation awards. She received 813 deferred stock units, each representing one share of ESAB common stock. She also received 2,647 stock options with a $100.94 exercise price that vested and became exercisable on the grant date. The deferred stock units vest in a single installment on June 1, 2027 and will be settled in common stock after her separation from the company.
ESAB Corp director Sebastien Martin received new equity awards. On May 8, 2026, he was granted 813 restricted stock units, each representing one share of ESAB common stock, and stock options for 2,647 shares at an exercise price of $100.94 per share.
The stock options vested and became exercisable on the grant date and expire on May 7, 2033. The restricted stock units vest in a single installment on June 1, 2027, aligning part of the director’s compensation with ESAB’s future share performance.
ESAB Corp director Melissa Cummings received new equity awards as part of her compensation. On May 8, 2026, she was granted 813 restricted stock units and 2,647 stock options linked to ESAB common stock.
The stock options carry an exercise price of $100.94 per share, vested and became exercisable on the grant date, and are scheduled to expire on May 7, 2033. The restricted stock units each represent a contingent right to receive one share of ESAB common stock and are set to vest in a single installment on June 1, 2027.
These awards are classified as acquisitions under a grant or award, not as open‑market purchases or sales, and result in post‑grant derivative holdings of 813 restricted stock units and 2,647 stock options directly owned by Cummings.
ESAB Corp director Rajiv Vinnakota reported receiving new equity awards. On May 8, 2026, he was granted 813 Restricted Stock Units, each representing one share of ESAB common stock. These RSUs vest in a single installment on June 1, 2027.
On the same date, he also received 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date and expire on May 7, 2033. After these grants, his reported holdings include 813 RSUs and 2,647 options, all held directly.
ESAB Corp director Didier P. Teirlinck received new equity awards as part of his compensation. On May 8, 2026, he was granted 406 restricted stock units and 407 deferred stock units, each representing a contingent right to receive one share of ESAB common stock.
The restricted and deferred stock units vest in a single installment on June 1, 2027, with the deferred units to be settled in ESAB common stock after his separation from the company. He also received stock options for 2,647 shares at an exercise price of $100.94 per share, which vested and became exercisable on the grant date and expire on May 7, 2033.
ESAB Corp director Robert S. Lutz received new equity-based compensation awards. He was granted 2,647 stock options with an exercise price of $100.94 per share that vested and became exercisable on the grant date. He also received 813 deferred stock units, each representing one share of common stock.
The 813 deferred stock units vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after his separation from the company. These awards are classified as grants rather than open-market purchases or sales and represent routine director compensation.
ESAB Corp director Rhonda L. Jordan reported awards of equity-based incentives. She received 813 deferred stock units, each tied to one share of ESAB common stock. These units vest in a single installment on June 1, 2027 and will be settled in stock after her separation from the company.
Jordan was also granted 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date of May 8, 2026 and will expire on May 7, 2033 if not exercised.
ESAB Corp director Mitchell P. Rales reported new equity awards and updated his holdings. On May 8, 2026, he received 813 shares of common stock as an annual equity grant in the form of restricted stock units that vest on June 1, 2027. He also received a stock option for 2,647 shares at an exercise price of $100.94 per share, which is fully vested and exercisable and expires on May 7, 2033. Following these awards, he directly holds 15,836 common shares, with additional indirect holdings through the Mitchell P. Rales Family Trust, a single-member LLC owned by a revocable trust for his benefit, and custodial accounts for his daughter, for which he disclaims beneficial ownership.
ESAB Corp reported that EVP and Chief Financial Officer R. Brent Jones received new equity awards. On May 7, 2026, he was granted 14,210 employee stock options to buy common stock at an exercise price of $102.3900 per share, expiring on May 6, 2033. These options vest in three equal annual installments starting on the first day of the month following each of the first three anniversaries of the grant date.
On the same date, Jones was also granted 33,978 restricted stock units, each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in three equal annual installments on the same schedule, aligning his compensation with the company’s future share performance.